Pure Biologics

Pure Biologics FCF Margin

The Free Cash Flow Margin of Pure Biologics (PUR.WA) as of Nov 12, 2026 is -24,671.58 %. In the previous year, Free Cash Flow Margin was -3,496.22 % — a change of 605.66% (lower).

FCF Margin

-24,671.58 %

YoY

605.66%

Last updated:

Free Cash Flow Margin of Pure Biologics is 2023 -24,671.58 % . Free Cash Flow Margin of Pure Biologics was 2022 -3,496.22 % . It decreases by 605.66% lower compared to the previous year.

The Pure Biologics FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2016
-89.36 PLN
Jan 1, 2017
-306.72 PLN
Jan 1, 2018
-27.80 PLN
Jan 1, 2019
30.88 PLN
Jan 1, 2020
-334.62 PLN
Jan 1, 2021
-9,727.56 PLN
Jan 1, 2022
-3,496.22 PLN
Jan 1, 2023
-24,671.58 PLN
The Pure Biologics FCF Margin history
YEARFCF MarginYoY
-24,671.58 %+605.66%
-3,496.22 %-64.06%
-9,727.56 %+2,807.09%
-334.62 %-1,183.72%
30.88 %-211.06%
-27.80 %-90.94%
-306.72 %+243.24%
-89.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pure Biologics Stock analysis

What does Pure Biologics do? Pure Biologics SA, headquartered in Wrocław, Poland, operates in the Health Care sector as a biotechnology company. It focuses on research and development of innovative biological medicines and medical devices for therapeutic and diagnostic applications. The company employs 53 full-time staff and was listed on the stock market on 11 December 2018. Founded in August 2010, it remains based in Wrocław, focusing on biopharmaceutical solutions. Pure Biologics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pure Biologics stock

Free Cash Flow Margin of Pure Biologics is -24,671.58 % in 2023.

Free Cash Flow Margin of Pure Biologics changed from -3,496.22 % to -24,671.58 %, representing a 605.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Pure Biologics with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Pure Biologics

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Pure Biologics